콘텐츠로 건너뛰기
Merck

주요 문서

모든 문서 보기

L8008

Luteinizing hormone releasing hormone

≥97% (HPLC)

동의어(들):

GnRH, Gonadotropin-releasing hormone, LH-RH, [Gly-OH10]-LH-RH, pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly

조직 및 계약 가격을 보려면 로그인를 클릭합니다.

크기 선택

보기 변경

제품정보 (DICE 배송 시 비용 별도)

실험식(Hill 표기법):
C55H74N16O14
CAS 번호:
35263-73-1
Molecular Weight:
1183.27
UNSPSC Code:
12352209
PubChem Substance ID:
24896489
NACRES:
NA.26
MDL number:
MFCD00167539
기술 서비스
도움이 필요하신가요? 저희 숙련된 과학자 팀이 도와드리겠습니다.
도움 문의

제품 이름

Luteinizing hormone releasing hormone, ≥97% (HPLC)

Quality Level

200

assay

≥97% (HPLC)

form

powder

color

white

application(s)

cell analysis

storage temp.

−20°C

SMILES string

CC(C)CC(NC(=O)CNC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CO)NC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc4cnc[nH]4)NC(=O)C5CCC(=O)N5)C(=O)NC(CCCNC(N)=N)C(=O)N6CCCC6C(=O)NCC(O)=O

InChI

1S/C55H74N16O14/c1-29(2)19-38(49(80)66-37(9-5-17-59-55(56)57)54(85)71-18-6-10-43(71)53(84)62-26-46(76)77)65-45(75)25-61-47(78)39(20-30-11-13-33(73)14-12-30)67-52(83)42(27-72)70-50(81)40(21-31-23-60-35-8-4-3-7-34(31)35)68-51(82)41(22-32-24-58-28-63-32)69-48(79)36-15-16-44(74)64-36/h3-4,7-8,11-14,23-24,28-29,36-43,60,72-73H,5-6,9-10,15-22,25-27H2,1-2H3,(H,58,63)(H,61,78)(H,62,84)(H,64,74)(H,65,75)(H,66,80)(H,67,83)(H,68,82)(H,69,79)(H,70,81)(H,76,77)(H4,56,57,59)

InChI key

IGACZQNUZMBGFX-UHFFFAOYSA-N

Biochem/physiol Actions

Luteinizing hormone releasing hormone (LH-RH) is used to release follicle-stimulating hormone (FSH) and luteinizing hormone (LH) from the anterior pituitary and to study many normal and pathological processes.

Packaging

Bottomless glass bottle. Contents are inside inserted fused cone.

저장 등급

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type P3 (EN 143) respirator cartridges

가장 최신 버전 중 하나를 선택하세요:

시험 성적서(COA)

Lot/Batch Number
1398545
068K1058
028K1474
087K1464
077K1453

적합한 버전을 찾을 수 없으신가요?

특정 버전이 필요한 경우 로트 번호나 배치 번호로 특정 인증서를 찾을 수 있습니다.

COA 검색

이 제품을 이미 가지고 계십니까?

문서 라이브러리에서 최근에 구매한 제품에 대한 문서를 찾아보세요.

문서 라이브러리 방문

Runa Özelçi et al.
Turkish journal of medical sciences, 49(4), 1138-1144 (2019-07-12)
Diminished ovarian reserve (DOR) represents a major challenge in reproductive medicine, as it is often associated with poor ovarian stimulation response, high cycle cancellation rate, and low pregnancy rate. The aim of the present study is to compare the
Mohannad Alharbi et al.
Asian journal of andrology, 22(4), 348-353 (2019-10-02)
Sperm DNA fragmentation (SDF) has been linked with male infertility, and previous studies suggest that SDF can have negative influence on pregnancy outcomes with assisted reproduction. We performed a retrospective review of consecutive couples with a high SDF level that
Daniel J Mathew et al.
Biology of reproduction, 100(2), 365-380 (2018-09-12)
This study investigated bovine conceptus-induced modifications to the endometrial transcriptome related to effects of interferon tau (IFNT), conceptus origin (in vivo vs. in vitro), and conceptus sex. In vitro (IVF) or in vivo (superovulation and artificial insemination, AI) produced blastocysts
모든 관련된 서류 보기